Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.70
+0.09 (1.36%)
At close: Apr 1, 2025, 4:00 PM
6.66
-0.04 (-0.55%)
After-hours: Apr 1, 2025, 4:07 PM EDT
Kamada Revenue
In the year 2024, Kamada had annual revenue of $160.95M with 12.93% growth. Kamada had revenue of $39.01M in the quarter ending December 31, 2024, with 7.06% growth.
Revenue (ttm)
$160.95M
Revenue Growth
+12.93%
P/S Ratio
2.41
Revenue / Employee
$383,221
Employees
420
Market Cap
387.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
KMDA News
- 13 days ago - Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewsWire
- 27 days ago - Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth - GlobeNewsWire
- 4 weeks ago - Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025 - GlobeNewsWire
- 2 months ago - Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America - GlobeNewsWire
- 4 months ago - Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston - GlobeNewsWire
- 8 months ago - Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript - Seeking Alpha